MARKET CENTER
BioIsrael Index
+2.5%
Analyst Reports
Volume IX Issue 2, 2010
BiolineRX $365 M Deal With Cypress
Protalix Phase I for BioDefense
Aposense IPO at $230 M
1,000 Int`l Visitors At ILSI Biomed
NovoCure Phase III Brain Cancer Success
Pain Management Investment Op
Can-Fite Drug Reduces HCV
Spatz FGIA Anti-Obesity Balloon in Spain
EarlySense Spots Patient Deterioration
Valtech Cardio Gets $17.8 M
Chiasma Phase I for Oral Delivery
LifeBond Raises $8 M
Prolor Dual Listing on TASE
IceCure Launches Tumor Removal
BioKine Phase I/II Cancer Trial Success
Metacure Diabetes Implant: 200 Patients
top of the page
